Investors may be looking at shares of Novavax, Inc. (NASDAQ:NVAX) with renewed interest over the past few trading sessions. After a recent scan, the stock has been seen trading near the $1.92 level. Staying on top of the equity market can be difficult. Knowing what information is important and how to interpret that information can be the difference between a good portfolio and a great one.
Investors are constantly looking for ways to find success in the stock market. Figuring out what stocks to buy can be tough. With so many different names to choose from, the task can seem quite overwhelming at times. Many investors will opt to go with a mix of growth and value stocks. Investors looking to capitalize on shorter-term price movements may have a completely different game plan than those who are looking to fin stocks to hold onto for the longer-term. Finding quality stocks that match the individual’s criteria may take a lot of effort and dedication, but it may be well worth it for the long-term success of the portfolio.
Shares of Novavax, Inc. (NASDAQ:NVAX) currently have an average target price of 4.38. This is the consensus number using estimates given by polled analysts. Professional sell-side analysts that track the stock are constantly monitoring the company to assess where they believe shares will be moving in the future. Price target projections can be calculated using various methods. Many investors will follow stock target prices, especially when analysts make revisions.
The average investor might not have the time to monitor every single movement of a certain stock. Tracking the historical performance may help provide some valuable insight on where the stock may be trending in the future. Looking back over the last 4 weeks, shares of Novavax, Inc. (NASDAQ:NVAX) have moved -8.13%. Over the last 5 days, the stock has seen a change of -12.73%. Looking at the last 12 week period, we note that the stock has moved -3.52%. Since the beginning of the calendar year, we note that shares have changed 4.35%. Investors will often track the current stock price relative to its 52-week high and low levels. The 52-week high is currently 2.48, and the 52-week low is resting at 1.17. When shares are trading near the 52-week high or 52-week low, investors may be on the lookout for a breakout.
Sell-side analysts often undertake stock analysis to give their opinions of whether they believe that shares should be bought, sold, or held. Using ratings provided by analysts polled by Zacks Research, we note that the current average broker rating on shares of Novavax, Inc. (NASDAQ:NVAX) is currently 1.44. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock. After a recent check, we can see that 7 sell-side analysts have rated the stock a Strong Buy or Buy, based analysts polled by Zacks Research. Professional investors often incorporate various strategies when approaching the stock market. Capitalizing on market dips can be highly profitable when thoroughly researched and executed. Closely monitoring earnings, news, and analyst views may play an important role in equity study.
New traders may face many challenges when entering the stock market. One of the bigger challenges involves not repeating mistakes. As with any new endeavor, there will be a learning curve. Paying attention to historical trades can help the trader figure out where they might have gone astray. Repeating the same mistakes over and over again can lead to the demise of the trader’s confidence and hard earned money. Traders who are able to move forward and learn from previous errors may find themselves making much better decisions in the future.
